Table 1. Results of intra-arterial therapy for metastatic breast cancer.
| Chemoembolization | |||
|---|---|---|---|
| Author | Year | N | Disease control (RECIST) |
| Lin et al 39 | 2017 | 23 | 83% |
| Eichler et al 36 | 2013 | 43 | 44% |
| Martin et al 38 | 2012 | 40 | 58% |
| Vogl et al 35 | 2011 | 161 | 56% |
| Cho et al 37 | 2010 | 10 | 40% |
| Vogl et al 34 | 2010 | 208 | 63% |
| Overall | 485 | 59% | |
| Radioembolization | |||
| Pieper et al 46 | 2016 | 44 | 71.1% |
| Gordon et al 44 | 2014 | 75 | 98.5% |
| Cianni et al 41 | 2013 | 52 | 91.4% |
| Saxena et al 43 | 2013 | 40 | 71.1% |
| Haug et al 40 | 2012 | 58 | 88% |
| Fendler et al 45 | 2016 | 81 | 52% |
| Overall | 335 | 78% | |
Abbreviation: RECIST, Response Evaluation Criteria in Solid Tumors.
Note: Disease control: complete response + partial response + stable disease by RECIST criteria.